#United States #Birmingham #Cresilon #TRAUMAGEL #Advanced Trauma

Cresilon to Showcase TRAUMAGEL Case Study at ATLS 2026

Cresilon Inc., a biotechnology firm based in Brooklyn, has recently announced an exciting development in the field of emergency medical response. The company is scheduled to present a poster detailing its retrospective clinical case series on TRAUMAGEL®, a cutting-edge hemostatic gel, at the 2026 Advanced Trauma Life Support® (ATLS®) Global Symposium. This prestigious event will take place from March 13 to 15 in Birmingham, Alabama.

Event Highlights

The presentation, titled "Prehospital Hemorrhage Control Using a Novel Flowable Gel: An Initial Case Series With TRAUMAGEL," will occur on March 14 from 5:00 to 6:00 p.m. CDT at the Sheraton Birmingham Hotel. This session will feature a panel of experts including David J. Kleiman, NRP; Tyler N. Carruth, MPA-C; James Infanzon, MD; Marvin E. Nix, MD; and Brian J. Goldstone, DO, all of whom will share insights about the clinical applications of TRAUMAGEL in emergency settings.

Cresilon’s representatives will be present during the poster session, ready to engage with attendees and discuss the deployment and efficacy of TRAUMAGEL in trauma care. Following the event, a copy of the presentation will be available for viewing on Cresilon’s official website.

About the Symposium

The ATLS Global Symposium, organized by the American College of Surgeons, is an annual gathering that attracts professionals from around the world dedicated to advancing trauma care through education and collaboration. The symposium promotes innovation and fosters relationships among medical professionals who specialize in trauma response and care.

Cresilon: Innovation in Hemostatic Technology

Founded with a mission to save lives, Cresilon specializes in developing hemostatic medical devices leveraging proprietary hydrogel technology. The company's formula has transformed the standard of care in emergency medicine by effectively controlling bleeding within seconds. TRAUMAGEL is not only a valuable tool for trauma care but also plays a critical role in various additional applications, including biosurgery and veterinary medicine.

Cresilon has received accolades for its innovation, recognized as one of the World’s Most Innovative Companies by Fast Company, and awarded the EMS World Innovation Award for TRAUMAGEL. As the healthcare industry continues to evolve, Cresilon remains at the forefront with a commitment to enhancing emergency response and saving lives in critical situations.

In summary, Cresilon's participation in the ATLS Global Symposium represents a significant opportunity for knowledge sharing and showcases the advancements in trauma care technology that are elevating patient outcomes. The company looks forward to connecting with industry leaders and sharing its innovative solutions that can change the course of emergency medical interventions.